Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Times Interest Earned: 2011-2025

Historic Times Interest Earned for Aytu Biopharma (AYTU) over the last 12 years, with Jun 2025 value amounting to -$2.11.

  • Aytu Biopharma's Times Interest Earned fell 211.53% to -$2.91 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.60, marking a year-over-year decrease of 454.22%. This contributed to the annual value of -$2.11 for FY2025, which is 390.74% down from last year.
  • According to the latest figures from FY2025, Aytu Biopharma's Times Interest Earned is -$2.11, which was down 390.74% from -$0.43 recorded in FY2024.
  • In the past 5 years, Aytu Biopharma's Times Interest Earned registered a high of -$0.43 during FY2024, and its lowest value of -$3.44 during FY2023.
  • Moreover, its 3-year median value for Times Interest Earned was -$2.11 (2025), whereas its average is -$1.99.
  • In the last 5 years, Aytu Biopharma's Times Interest Earned soared by 87.47% in 2024 and then tumbled by 390.74% in 2025.
  • Aytu Biopharma's Times Interest Earned (MRY) stood at -$3.44 in 2023, then surged by 87.47% to -$0.43 in 2024, then crashed by 390.74% to -$2.11 in 2025.
  • Its Times Interest Earned stands at -$2.11 for FY2025, versus -$0.43 for FY2024 and -$3.44 for FY2023.